Results 251 to 260 of about 14,200 (285)
Some of the next articles are maybe not open access.

Pancreatitis induced by mesalamine.

The Netherlands journal of medicine, 1992
Sulphasalazine is an active agent in the treatment of chronic inflammatory bowel disease, but there are a number of well-known side effects, including pancreatitis. The newer 5-ASA agents are thought to be equally effective but less toxic. Here we describe a patient who developed a pancreatitis due to mesalamine; this was confirmed at rechallenge.
F, Erdkamp   +4 more
openaire   +1 more source

Mesalamine and cholestyramine for immune checkpoint inhibitor-mediated diarrhea and colitis

Journal of Cancer Research and Clinical Oncology, 2022
Barbara Hollander   +9 more
semanticscholar   +1 more source

Colon-targeted 3D-Printed mesalamine tablets: Core-shell design and in vitro/ex-vivo evaluation

Journal of Drug Delivery Science and Technology
Nouf D. Alshammari   +6 more
semanticscholar   +1 more source

Pleuropericarditis related to the use of mesalamine

Digestive Diseases and Sciences, 1996
N, Gujral   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy